|
|
||||||||
From the Department of Immunology Research, Roswell Park Memorial Institute, 3 Buffalo, New York 14263
Abstract
The
G fractions of baboon and rabbit anti-MOLT-4 (a human leukemic T cell line) sera were extensively absorbed with glutaraldehyde-aggregated fetal calf serum and pools of normal human spleen cells and peripheral blood cells, both of which were derived from several different individuals. The spleen and peripheral blood cell preparations used contained normal T lymphocytes as well as B lymphocytes. The absorbed
G fractions were then further treated with several normal (nonmalignant) B cell lines that possessed HLA alloantigens known to be expressed on MOLT-4 cells. The resulting absorbed
G fractions of baboon (Abs-B
MOLT) and rabbit (Abs-R
MOLT) antisera were tested against thymocytes, leukemic T cell lines (MOLT-4, CCRF-CEM, CCRF-HSB-2, RPMI 8402) and a leukemic null cell line (NALM-1), various normal B cell lines, normal peripheral blood lymphocytes, normal spleen lymphocytes, and other control cells. Three different tests were used for both Abs-B
MOLT and Abs-R
MOLT: 1) A complement-dependent cytotoxicity test, 2) an 125I-antibody binding assay, and 3) a quantitative absorption-cytotoxicity test. Both the Abs-B
MOLT and Abs-R
MOLT that we used detected antigens common to the four leukemic T cell lines and to thymocytes and did not react with any of the control cells including normal T cells and cultured normal B cell lines. Abs-B
MOLT differed from Abs-R
MOLT in that only the former reacted with NALM-1, a leukemic null cell line, and only the latter reacted with an antigen(s) on MOLT-4 that was not detectable on thymocytes from certain donors. The Abs-R
MOLT was used for the isolation and partial characterization of the human thymus leukemia-associated antigens reported in the following paper.
Footnotes
1 This work was supported by Grant CA19304, awarded by the National Cancer Institute, Department of Health, Education and Welfare.
2 To whom correspondence should be sent.
3 A unit of the New York State Department of Health.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |